Literature DB >> 19075228

A postnatal switch of CELF and MBNL proteins reprograms alternative splicing in the developing heart.

Auinash Kalsotra1, Xinshu Xiao, Amanda J Ward, John C Castle, Jason M Johnson, Christopher B Burge, Thomas A Cooper.   

Abstract

From a large-scale screen using splicing microarrays and RT-PCR, we identified 63 alternative splicing (AS) events that are coordinated in 3 distinct temporal patterns during mouse heart development. More than half of these splicing transitions are evolutionarily conserved between mouse and chicken. Computational analysis of the introns flanking these splicing events identified enriched and conserved motifs including binding sites for CUGBP and ETR-3-like factors (CELF), muscleblind-like (MBNL) and Fox proteins. We show that CELF proteins are down-regulated >10-fold during heart development, and MBNL1 protein is concomitantly up-regulated nearly 4-fold. Using transgenic and knockout mice, we show that reproducing the embryonic expression patterns for CUGBP1 and MBNL1 in adult heart induces the embryonic splicing patterns for more than half of the developmentally regulated AS transitions. These findings indicate that CELF and MBNL proteins are determinative for a large subset of splicing transitions that occur during postnatal heart development.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19075228      PMCID: PMC2629332          DOI: 10.1073/pnas.0809045105

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

Review 1.  Alternative splicing: increasing diversity in the proteomic world.

Authors:  B R Graveley
Journal:  Trends Genet       Date:  2001-02       Impact factor: 11.639

2.  Alternative splicing in the human, mouse and rat genomes is associated with an increased frequency of exon creation and/or loss.

Authors:  Barmak Modrek; Christopher J Lee
Journal:  Nat Genet       Date:  2003-06       Impact factor: 38.330

Review 3.  How prevalent is functional alternative splicing in the human genome?

Authors:  Rotem Sorek; Ron Shamir; Gil Ast
Journal:  Trends Genet       Date:  2004-02       Impact factor: 11.639

4.  Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays.

Authors:  Jason M Johnson; John Castle; Philip Garrett-Engele; Zhengyan Kan; Patrick M Loerch; Christopher D Armour; Ralph Santos; Eric E Schadt; Roland Stoughton; Daniel D Shoemaker
Journal:  Science       Date:  2003-12-19       Impact factor: 47.728

5.  Ultraconserved elements in the human genome.

Authors:  Gill Bejerano; Michael Pheasant; Igor Makunin; Stuart Stephen; W James Kent; John S Mattick; David Haussler
Journal:  Science       Date:  2004-05-06       Impact factor: 47.728

6.  Identification of a (CUG)n triplet repeat RNA-binding protein and its expression in myotonic dystrophy.

Authors:  L T Timchenko; J W Miller; N A Timchenko; D R DeVore; K V Datar; L Lin; R Roberts; C T Caskey; M S Swanson
Journal:  Nucleic Acids Res       Date:  1996-11-15       Impact factor: 16.971

7.  Developmental changes in contractility and sarcomeric proteins from the early embryonic to the adult stage in the mouse heart.

Authors:  Sharon Siedner; Martina Krüger; Mechthild Schroeter; Doris Metzler; Wilhelm Roell; Bernd K Fleischmann; Juergen Hescheler; Gabriele Pfitzer; Robert Stehle
Journal:  J Physiol       Date:  2003-03-14       Impact factor: 5.182

8.  Muscleblind proteins regulate alternative splicing.

Authors:  Thai H Ho; Nicolas Charlet-B; Michael G Poulos; Gopal Singh; Maurice S Swanson; Thomas A Cooper
Journal:  EMBO J       Date:  2004-07-15       Impact factor: 11.598

9.  A muscleblind knockout model for myotonic dystrophy.

Authors:  Rahul N Kanadia; Karen A Johnstone; Ami Mankodi; Codrin Lungu; Charles A Thornton; Douglas Esson; Adrian M Timmers; William W Hauswirth; Maurice S Swanson
Journal:  Science       Date:  2003-12-12       Impact factor: 47.728

10.  Expression of 24,426 human alternative splicing events and predicted cis regulation in 48 tissues and cell lines.

Authors:  John C Castle; Chaolin Zhang; Jyoti K Shah; Amit V Kulkarni; Auinash Kalsotra; Thomas A Cooper; Jason M Johnson
Journal:  Nat Genet       Date:  2008-11-02       Impact factor: 38.330

View more
  258 in total

1.  Calcium-mediated histone modifications regulate alternative splicing in cardiomyocytes.

Authors:  Alok Sharma; Hieu Nguyen; Cuiyu Geng; Melissa N Hinman; Guangbin Luo; Hua Lou
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-03       Impact factor: 11.205

2.  Muscle weakness in myotonic dystrophy associated with misregulated splicing and altered gating of Ca(V)1.1 calcium channel.

Authors:  Zhen Zhi Tang; Viktor Yarotskyy; Lan Wei; Krzysztof Sobczak; Masayuki Nakamori; Katy Eichinger; Richard T Moxley; Robert T Dirksen; Charles A Thornton
Journal:  Hum Mol Genet       Date:  2011-12-02       Impact factor: 6.150

Review 3.  RNA-binding proteins in microsatellite expansion disorders: mediators of RNA toxicity.

Authors:  Gloria V Echeverria; Thomas A Cooper
Journal:  Brain Res       Date:  2012-02-22       Impact factor: 3.252

Review 4.  Vascular smooth muscle phenotypic diversity and function.

Authors:  Steven A Fisher
Journal:  Physiol Genomics       Date:  2010-08-24       Impact factor: 3.107

5.  MicroRNAs coordinate an alternative splicing network during mouse postnatal heart development.

Authors:  Auinash Kalsotra; Kun Wang; Pei-Feng Li; Thomas A Cooper
Journal:  Genes Dev       Date:  2010-03-18       Impact factor: 11.361

Review 6.  Role of noncoding RNAs in trinucleotide repeat neurodegenerative disorders.

Authors:  Huiping Tan; Zihui Xu; Peng Jin
Journal:  Exp Neurol       Date:  2012-01-27       Impact factor: 5.330

7.  Common variants near MBNL1 and NKX2-5 are associated with infantile hypertrophic pyloric stenosis.

Authors:  Bjarke Feenstra; Frank Geller; Camilla Krogh; Mads V Hollegaard; Sanne Gørtz; Heather A Boyd; Jeffrey C Murray; David M Hougaard; Mads Melbye
Journal:  Nat Genet       Date:  2012-02-05       Impact factor: 38.330

Review 8.  CELFish ways to modulate mRNA decay.

Authors:  Irina Vlasova-St Louis; Alexa M Dickson; Paul R Bohjanen; Carol J Wilusz
Journal:  Biochim Biophys Acta       Date:  2013-01-15

9.  Systemic therapy in an RNA toxicity mouse model with an antisense oligonucleotide therapy targeting a non-CUG sequence within the DMPK 3'UTR RNA.

Authors:  Ramesh S Yadava; Qing Yu; Mahua Mandal; Frank Rigo; C Frank Bennett; Mani S Mahadevan
Journal:  Hum Mol Genet       Date:  2020-06-03       Impact factor: 6.150

Review 10.  Antisense oligonucleotides: rising stars in eliminating RNA toxicity in myotonic dystrophy.

Authors:  Zhihua Gao; Thomas A Cooper
Journal:  Hum Gene Ther       Date:  2013-01-30       Impact factor: 5.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.